iPSC-based models have demonstrated a potential mechanism for the genetic susceptibility of APOE4 for cerebral amyloid angiopathy (CAA) associated with Alzheimer's disease (Blanchard et al., 2019)
A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
Our CJC-1295 buccal peptide strips deliver this powerful compound directly through the tissue under your tongue
This is only for those on the oral version, and has very little relevance to those on the injectables Zepbound and Wegovy
Incretin-based therapies for type 2 diabetes: a focus on glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors